1 / 7
Laboratory Research Material
PNC-27
30 mg per vial · Lyophilized powder
Laboratory Research Material
PNC-27 30 mg per vial
$249.99
- Compound
- PNC-27
- Amount per vial
- 30 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- 2 business daysEstimated transitFree
shipping On orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
PNC-27 30 mg
Buy PNC-27 30 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
PNC-27 is a designed peptide combining a p53-derived region with a membrane-active leader. It is studied in cell-membrane and HDM-2 research.
Choose the complete construct
The 2010 PNC-27 study specifies a 32-residue construct containing p53 residues 12-26 plus its membrane-active segment. The number 27 in the product name is not the complete amino-acid count. PNC-28 uses a different p53 segment and should not be treated as the same material.
Before comparing molecular specifications, check the full sequence, terminal chemistry and supplied form against the method you intend to use. A reference peptide’s identity does not replace analytical verification of a purchased batch.
The 30 mg label describes the amount supplied, while 3 mL describes the vial’s capacity. Neither specifies a prepared solution concentration or an experimental exposure level.
HDM-2 at the cell membrane
The original study used membrane-fraction analysis and fluorescence microscopy to examine HDM-2 and PNC-27 in cancer and nonmalignant cell models. The investigators observed PNC-27 and HDM-2 together at cancer-cell membranes, supporting a membrane-associated mechanism.
They also engineered initially nonsusceptible MCF-10-2A cells to express full-length HDM-2 at the membrane. Those cells became susceptible. This result makes the membrane context important; it does not support a blanket statement that every nonmalignant cell is spared.
These experiments concern particular cell systems and controls. They do not establish a treatment outcome or guarantee equivalent selectivity for another cell type or supplied preparation.
Product documents and batch identity
Use Documents to inspect the files available for this product. For any lot-specific report, confirm the product and batch match the material being evaluated. Identity evidence, chromatographic purity and measured content answer separate questions; a percentage alone cannot substitute for the other checks.
Confirm solvent compatibility, storage and stability of prepared material for your assay. General supplier handling statements or results obtained with another construct do not establish those conditions for this vial.
Additional information
| CAS No. | 1159861-00-3 |
|---|---|
| Purity | 98.885% (Janoshik report #199639, lot 28212) |
| Applications | Oncology studies, tumor necrosis assays, HDM-2 binding research, selective anti-cancer mechanisms |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
COA & Documents
Independent lot testing
PNC-27 30mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 28212
- Report number
- #199639
- Date tested
- July 8, 2026
- Reported purity
- 98.885%
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for PNC-27 30mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.

shipping